
Thursday, April 11, 2024 9:30:25 AM
Grabar Law Office is investigating claims on behalf of DocGo Inc. (NASDAQ: DCGO) shareholders. The investigation concerns whether certain officers and directors of DocGo have breached their fiduciary duties owed to the company as, on April 10th the New York City Mayor's office said that the mobile health services provider's $432M no-bid migrant services contract will not be renewed before it expires on May 5. Instead, the officials plan to issue a competitive request to select a new provider by year-end.
Current DocGo Inc. (NASDAQ: DCGO) shareholders who have held DocGo shares since on or before November 8, 2022, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever. Click: https://grabarlaw.com/the-latest/docgo-shareholder-investigation/.
An underlying securities fraud class action complaint was filed after the New York City's Comptroller announced that it was commencing a real-time audit of operations and invoices incurred by DocGo as the Comptroller had “serious concerns about the selection of this vendor and its performance of contract duties.”
On April 10, 2024, The New York City Mayor's office announced that the mobile health services provider's $432M no-bid migrant services contract will not be renewed before it expires on May 5. Instead, the officials plan to issue a competitive request to select a new provider by year-end.
DocGo share prices are down approximately 70% from previous trading highs.
If you would like to learn more about this matter, you are encouraged visit https://grabarlaw.com/the-latest/docgo-shareholder-investigation/, email Joshua Grabar at jgrabar @FH-6085.
$DCGO #DocGo
Recent DCGO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:34:23 PM
- DocGo to Provide Medical Transportation Services to Albany Stratton VA Medical Center • Business Wire • 07/01/2025 11:35:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2025 08:21:01 PM
- DocGo Announces Upcoming Participation in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2025 • Business Wire • 06/18/2025 11:35:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2025 08:22:48 PM
- DocGo Announces Upcoming Participation at the Goldman Sachs 46th Annual Global Healthcare Conference • Business Wire • 06/02/2025 11:35:00 AM
- Kuehn Law Encourages Investors of DocGo, Inc. to Contact Law Firm • PR Newswire (US) • 05/29/2025 05:20:00 PM
- DocGo Wins “Compliance Management Innovation Award” in 2025 MedTech Breakthrough Awards Program • Business Wire • 05/19/2025 11:35:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2025 09:41:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2025 09:39:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2025 08:35:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2025 08:15:49 PM
- DocGo Announces First Quarter 2025 Results • Business Wire • 05/08/2025 08:05:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/30/2025 02:53:25 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/24/2025 08:12:03 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/24/2025 08:11:07 PM
- DocGo to Announce First Quarter Results on Thursday, May 8, 2025 • Business Wire • 04/21/2025 11:35:00 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/14/2025 08:11:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2025 08:45:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2025 08:43:52 PM
- DocGo Earns Great Place To Work Certification™ For the Third Time in a Row • Business Wire • 03/31/2025 11:35:00 AM
- DocGo Announces Upcoming Participation at Needham Virtual Healthcare Conference • Business Wire • 03/24/2025 11:35:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2025 09:03:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2025 09:02:30 PM
FEATURED Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM
VAYK Discloses More Insider Buying Approaching 15 Million • VAYK • Jul 2, 2025 10:37 AM